You can:
Name | Galanin receptor type 3 |
---|---|
Species | Homo sapiens (Human) |
Gene | GALR3 |
Synonym | GAL3-R Galnr3 GALR-3 GALR3 GAL3 receptor |
Disease | Cognitive disorders |
Length | 368 |
Amino acid sequence | MADAQNISLDSPGSVGAVAVPVVFALIFLLGTVGNGLVLAVLLQPGPSAWQEPGSTTDLFILNLAVADLCFILCCVPFQATIYTLDAWLFGALVCKAVHLLIYLTMYASSFTLAAVSVDRYLAVRHPLRSRALRTPRNARAAVGLVWLLAALFSAPYLSYYGTVRYGALELCVPAWEDARRRALDVATFAAGYLLPVAVVSLAYGRTLRFLWAAVGPAGAAAAEARRRATGRAGRAMLAVAALYALCWGPHHALILCFWYGRFAFSPATYACRLASHCLAYANSCLNPLVYALASRHFRARFRRLWPCGRRRRHRARRALRRVRPASSGPPGCPGDARPSGRLLAGGGQGPEPREGPVHGGEAARGPE |
UniProt | O60755 |
Protein Data Bank | N/A |
GPCR-HGmod model | O60755 |
3D structure model | This predicted structure model is from GPCR-EXP O60755. |
BioLiP | N/A |
Therapeutic Target Database | T98494 |
ChEMBL | CHEMBL2731 |
IUPHAR | 245 |
DrugBank | N/A |
Name | MLS000712366 |
---|---|
Molecular formula | C16H14BrN3 |
IUPAC name | 2-benzyl-5-(4-bromophenyl)pyrazol-3-amine |
Molecular weight | 328.213 |
Hydrogen bond acceptor | 2 |
Hydrogen bond donor | 1 |
XlogP | 3.8 |
Synonyms | 2-benzyl-5-(4-bromophenyl)pyrazol-3-amine BAS 00831409 MolPort-001-947-713 STK757005 5-(4-bromophenyl)-2-(phenylmethyl)-3-pyrazolamine [ Show all ] |
Inchi Key | CKBWLLOYCRFXFT-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C16H14BrN3/c17-14-8-6-13(7-9-14)15-10-16(18)20(19-15)11-12-4-2-1-3-5-12/h1-10H,11,18H2 |
PubChem CID | 693933 |
ChEMBL | CHEMBL1547757 |
IUPHAR | N/A |
BindingDB | 46413 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 3553.0 nM | , PubChem BioAssay data set | BindingDB,ChEMBL |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218